Seeking Alpha

Tesaro (TSRO)

We currently have no Breaking News on this stock.
Company Description
Tesaro Inc is an oncology-focused biopharmaceutical company engaged in improving the lives of cancer patients. The Company is developing three clinical-stage product candidates including rolapitant, niraparib and TSR-011.
Sector: Healthcare
Industry: Biotechnology
Country: United States